TM4SF1 and pancreatic neoplasm: In the present study, we sought to determine whether TM4SF1 could confer pancreatic cancer with the ability to gemcitabine resistance.We found that TM4SF1 was highly expressed in gemcitabine-resistance pancreatic cancer cell lines.